↓ Skip to main content

Dove Medical Press

Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease

Overview of attention for article published in Drug, Healthcare and Patient Safety, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter
4 X users
patent
1 patent
facebook
1 Facebook page

Citations

dimensions_citation
9 Dimensions

Readers on

mendeley
21 Mendeley
Title
Anti-metallothionein IgG and levels of metallothionein in autistic children with GI disease
Published in
Drug, Healthcare and Patient Safety, January 2009
DOI 10.2147/dhps.s4342
Pubmed ID
Authors

Anthony Russo

Abstract

To assess both serum concentration of metallotionein (MT) and anti-metallothionein (anti-MT) immunoglobulin G (IgG) in autistic children with gastrointestinal (GI) symptoms and controls, and to test the hypothesis that there is an association between the presence of MT, anti-MT IgG, and inflammatory GI disease seen in many children with autistic spectrum disorder (ASD).

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 21 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 21 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 29%
Other 5 24%
Student > Doctoral Student 3 14%
Student > Ph. D. Student 2 10%
Professor > Associate Professor 2 10%
Other 2 10%
Unknown 1 5%
Readers by discipline Count As %
Medicine and Dentistry 6 29%
Agricultural and Biological Sciences 4 19%
Immunology and Microbiology 2 10%
Philosophy 1 5%
Psychology 1 5%
Other 1 5%
Unknown 6 29%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 12 December 2017.
All research outputs
#5,363,297
of 25,457,297 outputs
Outputs from Drug, Healthcare and Patient Safety
#59
of 160 outputs
Outputs of similar age
#28,446
of 183,651 outputs
Outputs of similar age from Drug, Healthcare and Patient Safety
#2
of 2 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 160 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.5. This one has gotten more attention than average, scoring higher than 63% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,651 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one.